Actively Recruiting
Study of Home Use of a Portable Device for Self-Administered Vagus Nerve Stimulation to Treat Chemotherapy-Induced Peripheral Neuropathy
Led by University of Miami · Updated on 2026-06-26
36
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the feasibility of using a portable device at home for self-administered transcutaneous auricular vagus nerve stimulation taVNS, which delivers mild electrical stimulation to the vagus nerve through the outer ear. The study focuses on cancer survivors with or without chemotherapy-induced peripheral neuropathy CIPN, exploring how taVNS may affect CIPN symptoms. Participants are divided into two groups based on the presence of CIPN to compare outcomes. Participants with CIPN will use a handheld taVNS device daily for 14 consecutive days, applying stimulation to specific ear areas for about 60 minutes each session with adjustable intensity below the pain threshold. Those without CIPN will join a registry group for observational comparison without receiving the stimulation. Both groups will undergo similar physiological assessments at baseline and after two weeks to control for variability. During the study, participants will complete baseline and follow-up assessments including symptom severity questionnaires, pain intensity scales, and serum biomarker tests. Researchers will monitor treatment adherence, retention, and acceptability of the intervention, as well as changes in neuropathic pain and physiological measures. The study includes a 28-day follow-up period after the intervention to track ongoing effects and outcomes.
CONDITIONS
Brief Title
Self-applied taVNS for CIPN
Research Team
R
Richard L Martinez, MSPH
M
Marlon L Wong, PT, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here